MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy

Background The study was undertaken to assess the efficacy of methotrexate (MTX) monotherapy on the radiographic progression of individual rheumatoid arthritis (RA) patients, each of whom had received MTX monotherapy for 3 years with an option to change to biological disease-modifying anti-rheumatic...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Shiozawa, Kazuko [verfasserIn]

Yamane, Takashi

Murata, Miki

Yoshihara, Ryosuke

Tsumiyama, Ken

Imura, Shigeaki

Shiozawa, Shunichi

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2016

Schlagwörter:

Rheumatoid arthritis

Radiographic remission

Radiographic progression

Predictor

Matrix metalloproteinase-3

MMP-3

Methotrexate (MTX) monotherapy

Anmerkung:

© Shiozawa et al. 2016

Übergeordnetes Werk:

Enthalten in: Arthritis Research & Therapy - London : BioMed Central, 1999, 18(2016), 1 vom: 27. Feb.

Übergeordnetes Werk:

volume:18 ; year:2016 ; number:1 ; day:27 ; month:02

Links:

Volltext

DOI / URN:

10.1186/s13075-016-0948-7

Katalog-ID:

SPR030222567

Nicht das Richtige dabei?

Schreiben Sie uns!